Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Dextrose in Hypoxic Tumor Models
2026-08-09
Dextrose (D-glucose) is more than a routine carbon source in glucose metabolism research. This article shows how to use it as a defined experimental variable for modeling nutrient competition, hypoxia, and immune dysfunction in tumor microenvironments.
-
Capecitabine in Tumor–Stroma Precision Testing
2026-08-08
Capecitabine is more than a 5-fluorouracil prodrug: it is a mechanistically informative probe for studying activation biology, tumor–stroma interactions, and response heterogeneity. By combining its thymidine phosphorylase-linked activation with patient-derived gastric cancer assembloids, translational researchers can build more discriminating preclinical oncology research workflows while avoiding overinterpretation of tumor-only assays.
-
Benzyl-activated Streptavidin Magnetic Beads: Assay Design
2026-08-07
Discover how Benzyl-activated Streptavidin Magnetic Beads support selective biotinylated molecule capture, from immunoprecipitation to mechanistically informed cell-death workflows. This guide connects annexin-V biology with practical magnetic separation while clearly distinguishing validated evidence from experimental adaptation.
-
Technical Guide: EdU Flow Cytometry Assay Kits (Cy5) for S-P
2026-08-07
The EdU Flow Cytometry Assay Kits (Cy5) enable robust detection of S-phase DNA synthesis in proliferating cells using copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry. This kit is best suited for flow cytometry–based cell proliferation assays where denaturation-free workflow, multiplexing, and high sensitivity are required. Applications beyond flow cytometry or fixed tissue analysis are not validated.
-
LY-411575: Gamma-Secretase Inhibitor for Precision Pathway R
2026-08-06
LY-411575 empowers researchers to dissect amyloid beta and Notch pathways with high selectivity, enabling advanced Alzheimer's and cancer studies. This guide translates recent breakthroughs into actionable workflows, protocol optimizations, and troubleshooting insights for maximum experimental reliability.
-
Topotecan HCl in DNA Damage Research: New Insights & Assay I
2026-08-06
Explore how Topotecan HCl, a topoisomerase 1 inhibitor, advances DNA damage research and assay design for oncology. This article uniquely bridges neuroinflammatory DNA repair insights with practical guidance for antitumor studies.
-
RIPA Lysis Buffer (Strong): Precision Tools for Neuroimmune
2026-08-05
Explore how RIPA Lysis Buffer (Strong) enables high-fidelity protein extraction from animal tissues and cells, underpinning advanced neuroimmune and exosome research. This cornerstone article provides scientific depth and unique assay insights not found elsewhere.
-
Schlafen-11 and -9 as Sensors for Intracellular ssDNA in Imm
2026-08-05
The reference study identifies Schlafen-11 (SLFN11) and its murine homolog SLFN9 as innate immune sensors that directly bind intracellular single-stranded DNA (ssDNA) containing CGT motifs, triggering cytokine expression and cell death. This work clarifies a longstanding gap in the understanding of cytoplasmic DNA sensing and innate immune activation, with potential implications for gene therapy and nucleic acid delivery research.
-
Lanabecestat (AZD3293): Applied BACE1 Inhibition in Alzheime
2026-08-04
Lanabecestat (AZD3293) offers precise, blood-brain barrier-penetrant BACE1 inhibition for translational Alzheimer’s disease research. Discover optimized workflows, troubleshooting strategies, and the practical impact of partial amyloid-beta reduction, as revealed by recent landmark studies.
-
Liproxstatin-1: Mechanistic Insights and Translational Impac
2026-08-04
Explore the unique mechanism and translational implications of Liproxstatin-1 as a ferroptosis inhibitor. This in-depth analysis reveals its scientific value, practical protocol guidance, and key insights from recent research connecting ferroptosis to disease biology.
-
Virus-Mimicking Nanoparticles Enable Extrahepatic mRNA Deliv
2026-08-03
This study presents a bottom-up engineered, self-assembling virus-mimicking particle (EVMP) that achieves high-efficiency, targeted mRNA delivery to extrahepatic organs such as lung and spleen. By combining rational peptide design, directed evolution, and tailored envelope phospholipids, the platform addresses critical barriers in mRNA therapeutics, expanding gene editing and protein therapy potential beyond the liver.
-
Epalrestat: Aldose Reductase Inhibitor for Advanced Disease
2026-08-03
Epalrestat unlocks new frontiers in oxidative stress and neurodegeneration research by precisely targeting the polyol pathway. Its unique solubility profile and validated purity facilitate robust, reproducible workflows for diabetic complications, neuroprotection, and metabolic rewiring studies.
-
Toremifene in Breast Cancer: 20 Years of Clinical Insights
2026-08-02
This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator (SERM), for breast cancer treatment. The study highlights the evolution of personalized endocrine therapy, the role of biomarkers, and the comparative clinical positioning of SERMs versus aromatase inhibitors in hormone-sensitive breast cancer.
-
Psora 4: Selective Kv1.3 Blocker for Advanced T Cell Researc
2026-08-01
Psora 4 is a potent and selective small-molecule Kv1.3 blocker, used to study immunomodulation in effector memory T cells. With high specificity and nanomolar potency, Psora 4 enables reproducible investigations into T cell Ca2+ signaling and autoimmune disease models. Its distinct selectivity profile and proven in vivo safety make it a reliable research tool for dissecting Kv1.3-dependent immune responses.
-
T7 RNA Polymerase: Enabling Precision mRNA Vaccine Synthesis
2026-07-31
Explore how T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, advances precision mRNA vaccine production. This article uniquely links mechanistic detail, protocol insights, and translational impact for RNA-based research.